Smith BD - Search Results

1

Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.

Shah NP, Bhatia R, Altman JK, Amaya M, Begna KH, Berman E, Chan O, Clements J, Collins RH, Curtin PT, DeAngelo DJ, Drazer M, Maness L, Metheny L, Mohan S, Moore JO, Oehler V, Pratz K, Pusic I, Rose MG, Shomali W, Smith BD, Styler M, Talpaz M, Tanaka TN, Tantravahi S, Thompson J, Tsai S, Vaughn J, Welborn J, Yang DT, Sundar H, Gregory K. Shah NP, et al. Among authors: smith bd. J Natl Compr Canc Netw. 2024 Feb;22(1):43-69. doi: 10.6004/jnccn.2024.0007. J Natl Compr Canc Netw. 2024. PMID: 38394770

2

Imatinib for chronic myeloid leukemia: the impact of its effectiveness and long-term side effects.

Smith BD. Smith BD. J Natl Cancer Inst. 2011 Apr 6;103(7):527-9. doi: 10.1093/jnci/djr073. Epub 2011 Mar 21. J Natl Cancer Inst. 2011. PMID: 21422404 No abstract available.

3

Adding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): a Multicenter, Randomized Phase II Trial.

Reddy JP, Sherry AD, Fellman B, Liu S, Bathala T, Haymaker C, Cohen L, Smith BD, Ramirez D, Shaitelman SF, Chun SG, Medina-Rosales M, Teshome M, Brewster A, Barcenas CH, Reuben A, Ghia AJ, Ludmir EB, Weed D, Shah SJ, Mitchell MP, Woodward WA, Gomez DR, Tang C. Reddy JP, et al. Among authors: smith bd. Int J Radiat Oncol Biol Phys. 2024 Oct 30:S0360-3016(24)03522-3. doi: 10.1016/j.ijrobp.2024.10.030. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 39486645

4

The effect of body mass index on the safety of bosutinib in patients with chronic leukemia: A post hoc pooled data analysis.

Isfort S, Gambacorti-Passerini C, Brümmendorf TH, Smith BD, Purcell S, Strecker M, Zhao H, Kuttschreuter L, Apperley J. Isfort S, et al. Among authors: smith bd. Leuk Res. 2024 Oct 24;147:107609. doi: 10.1016/j.leukres.2024.107609. Online ahead of print. Leuk Res. 2024. PMID: 39471734 No abstract available.

5

ASO Visual Abstract: Impact of Clipped Node as a Sentinel Lymph Node on Axillary Staging Following Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer.

Moore AM, Caudle AS, Sun SX, Yi M, Smith BD, Valero V, Yang W, Kuerer HM, Hunt KK, Teshome M. Moore AM, et al. Among authors: smith bd. Ann Surg Oncol. 2024 Oct 23. doi: 10.1245/s10434-024-16397-0. Online ahead of print. Ann Surg Oncol. 2024. PMID: 39443343 No abstract available.

6

Impact of Clipped Node as a Sentinel Lymph Node on Axillary Staging Following Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer.

Moore AM, Caudle AS, Sun SX, Yi M, Smith BD, Valero V, Yang W, Kuerer HM, Hunt KK, Teshome M. Moore AM, et al. Among authors: smith bd. Ann Surg Oncol. 2024 Oct 17. doi: 10.1245/s10434-024-16341-2. Online ahead of print. Ann Surg Oncol. 2024. PMID: 39419889

7

Automated, Real-Time Integration of Biometric Data From Wearable Devices With Electronic Medical Records: A Feasibility Study.

Weng JK, Virk R, Kaiser K, Hoffman KE, Goodman CR, Mitchell M, Shaitelman S, Schlembach P, Reed V, Wu CF, Xiao L, Smith GL, Smith BD. Weng JK, et al. Among authors: smith bd. JCO Clin Cancer Inform. 2024 Sep;8:e2400040. doi: 10.1200/CCI.24.00040. Epub 2024 Sep 30. JCO Clin Cancer Inform. 2024. PMID: 39348612 Free article.

8

Financial toxicity in breast cancer patients receiving regional nodal irradiation: Variation by cancer subtype.

Smith GL, Smith BD, Wu CF, Shaitelman SF, Chavez-MacGregor M, Murthy R, Kaiser K, Ku KS, Shi JJ, Shete SS, Chen YS, Volk RJ, Giordano SH, Shih YT, Hoffman KE. Smith GL, et al. Among authors: smith bd. Breast. 2024 Sep 21;78:103813. doi: 10.1016/j.breast.2024.103813. Online ahead of print. Breast. 2024. PMID: 39321504 Free PMC article.

9

Feasibility of breast conserving surgery alone in HER2-positive exceptional responders to neoadjuvant systemic therapy.

Mitchell MP, Shaitelman SF, Smith BD, Krishnamurthy S, Valero V, Rauch GM, Shen Y, Lin H, Kuerer HM. Mitchell MP, et al. Among authors: smith bd. Eur J Surg Oncol. 2024 Aug 22;50(12):108613. doi: 10.1016/j.ejso.2024.108613. Online ahead of print. Eur J Surg Oncol. 2024. PMID: 39243728

10

Inhibition of ULK1/2 and KRAS^G12C controls tumor growth in preclinical models of lung cancer.

Ghazi PC, O'Toole KT, Srinivas Boggaram S, Scherzer MT, Silvis MR, Zhang Y, Bogdan M, Smith BD, Lozano G, Flynn DL, Snyder EL, Kinsey CG, McMahon M. Ghazi PC, et al. Among authors: smith bd. Elife. 2024 Aug 30;13:RP96992. doi: 10.7554/eLife.96992. Elife. 2024. PMID: 39213022 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,114 results

Search Page

Filters